• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.

作者信息

Marchetti Matteo, Barelli Stefano, Gleich Tobias, Gomez Francisco J, Goodyer Matthew, Grandoni Francesco, Alberio Lorenzo

机构信息

Division of Hematology and Central Laboratory of Hematology, CHUV, Lausanne University Hospital, Lausanne, Switzerland.

Faculty of Biology and Medicine, UNIL, University of Lausanne, Lausanne, Switzerland.

出版信息

Br J Haematol. 2022 Jun;197(6):766-790. doi: 10.1111/bjh.18120. Epub 2022 Mar 31.

DOI:10.1111/bjh.18120
PMID:35358358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9324832/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/2d74324834bf/BJH-197-766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/e4b544428643/BJH-197-766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/208ec2d2d6bb/BJH-197-766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/6c9fb952d0b3/BJH-197-766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/65e31b94d509/BJH-197-766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/f208fb3214ef/BJH-197-766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/50d876305e8d/BJH-197-766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/cc4c25fe80ae/BJH-197-766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/2d74324834bf/BJH-197-766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/e4b544428643/BJH-197-766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/208ec2d2d6bb/BJH-197-766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/6c9fb952d0b3/BJH-197-766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/65e31b94d509/BJH-197-766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/f208fb3214ef/BJH-197-766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/50d876305e8d/BJH-197-766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/cc4c25fe80ae/BJH-197-766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41bc/9324832/2d74324834bf/BJH-197-766-g003.jpg

相似文献

1
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.肝素诱导的血小板减少症中阿加曲班的管理：对32例确诊肝素诱导的血小板减少症患者729个治疗日的回顾性分析。
Br J Haematol. 2022 Jun;197(6):766-790. doi: 10.1111/bjh.18120. Epub 2022 Mar 31.
2
Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.重症监护病房中伴有多器官功能障碍综合征的肝素诱导血小板减少症患者的阿加曲班治疗：一项回顾性研究。
Crit Care. 2010;14(3):R90. doi: 10.1186/cc9024. Epub 2010 May 20.
3
[Low-dose argatroban emerging salvage therapies for heparin-induced thrombocytopenia during artificial liver treatment: a case report].[低剂量阿加曲班用于人工肝治疗期间肝素诱导的血小板减少症的新兴挽救疗法：一例报告]
Zhonghua Gan Zang Bing Za Zhi. 2021 Dec 20;29(12):1198-1200. doi: 10.3760/cma.j.cn501113-20201215-00655.
4
The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.阿加曲班在肝素诱导的血小板减少症患者颈动脉内膜切除术中的应用。
Anesth Analg. 2005 Apr;100(4):946-948. doi: 10.1213/01.ANE.0000146940.47989.5F.
5
Argatroban as Purge Solution in Patients With Heparin-Induced Thrombocytopenia on an Impella Device.阿加曲班作为使用Impella装置的肝素诱导血小板减少症患者的冲洗液
Am J Ther. 2020 Jun 1;28(6):e763-e765. doi: 10.1097/MJT.0000000000001114.
6
Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.阿加曲班治疗冠状动脉疾病合并肝素诱导的血小板减少症患者。
Cardiology. 2008;109(3):172-6. doi: 10.1159/000106678. Epub 2007 Aug 28.
7
How we manage patients with heparin induced thrombocytopenia.如何管理肝素诱导的血小板减少症患者。
Br J Haematol. 2016 Jul;174(1):9-15. doi: 10.1111/bjh.14102. Epub 2016 Apr 21.
8
A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).一例在肝素诱导的血小板减少症（HIT）中使用DOAC-stop成功从阿加曲班转换为华法林的病例报告。
Pathology. 2021 Oct;53(6):800-802. doi: 10.1016/j.pathol.2020.10.018. Epub 2021 Feb 17.
9
Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.降低抗凝相关危害：阿加曲班治疗肝素诱导的血小板减少症的实际考量
Drug Saf. 2009;32(3):203-18. doi: 10.2165/00002018-200932030-00003.
10
Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.仅接受肝素进行血液透析的患者发生肝素诱导的血小板减少症。
Ren Fail. 2006;28(7):537-9. doi: 10.1080/08860220600843813.

引用本文的文献

1
Pitfalls in Argatroban Monitoring: Heparin Interference With Dilute Thrombin Time Assays.阿加曲班监测中的陷阱：肝素对稀释凝血酶时间测定的干扰。
Int J Lab Hematol. 2025 Oct;47(5):989-991. doi: 10.1111/ijlh.14505. Epub 2025 May 26.
2
A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease.一种用于监测青紫型和复杂性先天性心脏病患者直接口服抗凝剂的新策略。
Int J Cardiol Congenit Heart Dis. 2024 Sep 25;18:100545. doi: 10.1016/j.ijcchd.2024.100545. eCollection 2024 Dec.
3
Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro.

本文引用的文献

1
Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.阿加曲班治疗肝素诱导的血小板减少症的疗效更佳：贝叶斯网状meta 分析。
Int J Clin Pharm. 2021 Aug;43(4):825-838. doi: 10.1007/s11096-021-01260-z. Epub 2021 Mar 28.
2
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland.瑞士关于使用抗凝剂治疗肝素诱导的血小板减少症患者的建议。
Swiss Med Wkly. 2020 Apr 24;150:w20210. doi: 10.4414/smw.2020.20210. eCollection 2020 Apr 20.
3
Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
利用新型的粘弹性凝血仪 ClotPro 检测依诺肝素和阿加曲班。
Sci Rep. 2024 Nov 27;14(1):29520. doi: 10.1038/s41598-024-81396-w.
4
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.肝素诱导的血小板减少症生物标志物发现的蛋白质组学分析。
Blood Adv. 2024 Jun 11;8(11):2825-2834. doi: 10.1182/bloodadvances.2024012782.
5
How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass.如何解决体外循环期间肝素诱导的血小板减少症这一难题。
J Clin Med. 2023 Jan 18;12(3):786. doi: 10.3390/jcm12030786.
6
Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia.快速免疫检测组合用于快速诊断肝素诱导的血小板减少症。
J Thromb Haemost. 2022 Oct;20(10):2407-2418. doi: 10.1111/jth.15811. Epub 2022 Jul 27.
快速准确的贝叶斯诊断肝素诱导的血小板减少症。
Blood. 2020 Apr 2;135(14):1171-1184. doi: 10.1182/blood.2019002845.
4
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.美国血液学会 2018 年静脉血栓栓塞症管理指南：肝素诱导的血小板减少症。
Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489.
5
Heparin-Induced Thrombocytopenia in the Critically Ill Patient.危重症患者的肝素诱导血小板减少症。
Chest. 2018 Sep;154(3):678-690. doi: 10.1016/j.chest.2017.11.039. Epub 2017 Dec 16.
6
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.直接口服抗凝剂治疗 HIT：汉密尔顿经验更新及文献回顾。
Blood. 2017 Aug 31;130(9):1104-1113. doi: 10.1182/blood-2017-04-778993. Epub 2017 Jun 23.
7
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者队列的临床结局。
Am J Hematol. 2017 Aug;92(8):730-738. doi: 10.1002/ajh.24759. Epub 2017 Apr 26.
8
Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia.阿加曲班在疑似肝素诱导血小板减少症的重症心脏手术患者中的药代动力学和药效学。
Thromb Haemost. 2016 Jun 2;115(6):1081-9. doi: 10.1160/TH15-11-0847. Epub 2016 Jan 21.
9
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.阿加曲班用于肝素诱导的血小板减少症的治疗：一项多中心临床试验。
Crit Care. 2015 Nov 11;19:396. doi: 10.1186/s13054-015-1109-0.
10
Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.比伐芦定与重组水蛭素和阿加曲班在肝素诱导的血小板减少症患者中的比较。
Am J Health Syst Pharm. 2015 Sep 1;72(17 Suppl 2):S104-9. doi: 10.2146/sp150018.